(Q38107140)

29 August 2017

Treatment strategies for gastric cancer patients with peritoneal metastasis (English)

1 reference

29 August 2017

Motohiro Imano

1

1 reference

PubMed ID

23677598

29 August 2017

Kiyotaka Okuno

series ordinal

2

1 reference

29 August 2017

16 May 2013

1 reference

29 August 2017

1 reference

29 August 2017

44

1 reference

29 August 2017

3

1 reference

29 August 2017

399-404

1 reference

Recent advances in chemotherapy for advanced gastric cancer in Japan

29 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Investigation of the recurrence patterns of gastric cancer following a curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Chemotherapy for metastatic disease: review from JCOG trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-Fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0603-8

A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis

21 January 2018

1 reference

12 December 2020

Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis

1 reference

12 December 2020

A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study)

1 reference

12 December 2020

Gastric cancer: a 25-year review

1 reference

12 December 2020

Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group

1 reference

12 December 2020

Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study.

1 reference

12 December 2020

Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2

1 reference

12 December 2020

Phase II study of paclitaxel in pretreated advanced gastric cancer

1 reference

12 December 2020

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

12 December 2020

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study

1 reference

12 December 2020

Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.

1 reference

12 December 2020

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study

1 reference

12 December 2020

Standard chemotherapy for gastric carcinoma: is it a myth?

1 reference

12 December 2020

Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis

1 reference

12 December 2020

Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.

1 reference

12 December 2020

High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer

1 reference

12 December 2020

A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial)

1 reference

12 December 2020

10.1007/S00595-013-0603-8

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23677598